Clinical Trials Browser

Phase 2 × Radiation Pneumonitis × aumolertinib × Clear all

NCT04636593 2021-01-12

A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Radiation Pneumonitis